NF-κB, but not p38 MAP kinase, is required for TNF-α-induced expression of cell adhesion molecules in endothelial cells

Journal of Cellular Biochemistry

Volumn 105, Issue 2, 2008, Pages 477-486

  Rajan, Suja ^a   Ye, Jianming ^a   Bai, Shanshan ^a   Huang, Faqing ^a   Guo, Yan Lin ^a  

^a The University of Southern Mississippi   (United States)

Author keywords

Cell adhesion molecules; Endothelial cells; NF B; p38 MAP kinase; TNF

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LEVEL; CONTROLLED STUDY; DRUG INHIBITION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; UMBILICAL VEIN; ANIMAL; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION MOLECULES; E-SELECTIN; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; IMIDAZOLES; INTERCELLULAR ADHESION MOLECULE-1; MICE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 54849431788     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21845     Document Type: Article

References (46)

1. Aird WC. 2007. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100:158-173.
2. Allen M, Svensson L, Roach M, Hambor J, McNeish J, Gabel CA. 2000. Deficiency of the stress kinase p38{alpha} results in embryonic lethality: Characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp Med 191:859-870.
3. Baud V, Karin M. 2001. Signal transduction by tumor necrosis factor and its relatives. Trend Cell Biol 11:372-377.
4. Beyaert R, Fiers W. 1994. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not. FEBS Lett 340:9-16.
5. Clarke CJ, Truong TG, Hannun YA. 2007. Role for Neutral sphingomyelinase-2 in tumor necrosis factor {alpha}-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: p38 MAPK is an upstream regulator of nSMase2. J Biol Chem 282:1384-1396.
6. Coffey ET, Smiciene G, Hongisto V, Cao J, Brecht S, Herdegen T, Courtney MJ. 2002. c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons. J Neurosci 22:4335-4345.
7. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-233.
8. Davies SP, Reddy H, Caivano M, Cohen P. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105.
9. Denk A, Goebeler M, Schmid S, Berberich I, Ritz O, Lindemann D, Ludwig S, Wirth T. 2001. Activation of NF-kappa B via the I-kappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem 276:28451-28458.
10. Fitau J, Boulday G, Coulon F, Quillard T, Charreau B. 2006. The adaptor molecule lnk negatively regulates tumor necrosis factor-{alpha}-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and -2 pathways. J Biol Chem 281:20148-20159.
11. Gaur U, Aggarwal BB. 2003. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 66:1403-1408.
12. Goebeler M, Kilian K, Gillitzer R, Kunz M, Yoshimura T, Brocker EB, Rapp UR, Ludwig S. 1999. The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-alpha-induced expression of monocyte-chemoattractant protein-1 in endothelial cells. Blood 93:857-865.
13. Grivennikov SI, Kuprash DV, Liu Z, Nedospasov SA. 2006. Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms. In: WJ, Kwang editor. International review of cytology a survey of cell biology. New York: Academic Press. pp 129-161.
14. Gum RJ, McLaughlin MM, Kumar S, Wang Z, Bower MJ, Lee JC, Adams JL, Livi GP, Goldsmith EJ, Young PR. 1998. Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem 273:15605-15610.
15. Guo YL, Kang B, Han J, Williamson JR. 2001. p38beta MAP kinase protects rat mesangial cells from TNF-alpha-induced apoptosis. J Cell Biochem 82:556-565.
16. Guo YL, Ye J, Huang F. 2007. p38alpha MAP kinase-deficient mouse embryonic stem cells can differentiate to endothelial cells, smooth muscle cells, and neurons. Dev Dyn 236:3383-3392.
17. Hartsfield CL, Alam J, Choi AMK. 1998. Transcriptional regulation of the heme oxygenase 1 gene by pyrrolidine dithiocarbamate. FASEB J 12:1675-1682.
18. Holden NS, Catley MC, Cambridge LM, Barnes PJ, Newton R. 2004. ICAM-1 expression is highly NF-kappaB-dependent in A549 cells. No role for ERK and p38 MAPK. Eur J Biochem 271:785-791.
19. Jiang MZ, Tsukahara H, Ohshima Y, Todoroki Y, Hiraoka M, Maeda M, Mayumi M. 2004. Effects of antioxidants and nitric oxide on TNF-[alpha]-induced adhesion molecule expression and NF-[kappa]B activation in human dermal microvascular endothelial cells. Life Sci 75:1159-1170.
20. Ju H, Behm DJ, Nerurkar S, Eybye ME, Haimbach RE, Olzinski AR, Douglas SA, Willette RN. 2003. p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension. J Pharmacol Exp Ther 307:932-938.
21. Kang YJ, Seit-Nebi A, Davis RJ, Han J. 2006. Multiple activation mechanisms of p38{alpha} mitogen-activated protein kinase. J Biol Chem 281:26225-26234.
22. Karin M. 2005. Inflammation-activated protein kinases as targets for drug development. Proc Am Thorac Soc 2:386-390.
23. Kuldo JM, Westra J, Asgeirsdottir SA, Kok RJ, Oosterhuis K, Rots MG, Schouten JP, Limburg PC, Molema G. 2005. Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro. Am J Physiol Cell Physiol 289:C1229-C1239.
24. Laferriere J, Houle F, Taher MM, Valerie K, Huot J. 2001. Transendothelial migration of colon carcinoma cells requires expression of e-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem 276:33762-33772.
25. Lali FV, Hunt AE, Turner SJ, Foxwell BMJ. 2000. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase. J Biol Chem 275:7395-7402.
26. Lee DH, Goldberg AL. 1998. Proteasome inhibitors: Valuable new tools for cell biologists. Trend Cell Biol 8:397-403.
27. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Keys JR, Land vatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
28. Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL. 2000. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 47:185-201.
29. Lin SJ, Shyue SK, Hung YY, Chen YH, Ku HH, Chen JW, Tam KB, Chen YL. 2005. Superoxide dismutase inhibits the expression of vascular cell adhesion molecule-1 and intracellular cell adhesion molecule-1 induced by tumor necrosis factor-{alpha} in human endothelial cells through the JNK/p38 pathways. Arterioscler Thromb Vasc Biol 25:334-340.
30. May MJ, Ghosh S. 1998. Signal transduction through NF-[kappa]B. Immunol Today 19:80-88.
31. McCloskey KE, Smith DA, Jo H, Nerem RM. 2006. Embryonic stem cell-derived endothelial cells may lack complete functional maturation in vitro. J Vasc Res 43:411-421.
32. Mechtcheriakova D, Schabbauer G, Lucerna M, Clauss M, De Martin R, Binder BR, Hofer E. 2001. Specificity, diversity, and convergence in VEGF and TNF-{alpha} signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells. FASEB J 15:230-242.
33. Milstone DS, O'Donnell PE, Stavrakis G, Mortensen RM, Davis VM. 2000. E-selectin expression and stimulation by inflammatory mediators are developmentally regulated during embryogenesis. Lab Invest 80:943-954.
34. Ono K, Han J. 2000. The p38 signal transduction pathway: Activation and function. Cell Signal 12:1-13.
35. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
36. Pietersma A, Tilly BC, Gaestel M, de Jong N, Lee JC, Koster JF, Sluiter W. 1997. P38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem Biophys Res Comm 230:44-48.
37. Read MA, Whitley MZ, Gupta S, Pierce JW, Best J, Davis RJ, Collins T. 1997. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem 272:2753-2761.
38. Vailhe B, Vittet D, Feige JJ. 2001. In vitro models of vasculogenesis and angiogenesis. Lab Invest 81:439-452.
39. Viemann D, Goebeler M, Schmid S, Klimmek K, Sorg C, Ludwig S, Roth J. 2004. Transcriptional profiling of IKK2/NF-{kappa}B-and p38 MAP kinasedependent gene expression in TNF-{alpha}-stimulated primary human endothelial cells. Blood 103:3365-3373.
40. Westra J, Kuldo JM, van Rijswijk MH, Molema G, Limburg PC. 2005. Chemokine production and E-selectin expression in activated endothelial cells are inhibited by p38 MAPK (mitogen activated protein kinase) inhibitor RWJ 67657. Int Immunopharmacol 5:1259-1269.
41. Woo CH, Lim JH, Kim JH. 2005. VCAM-1 upregulation via PKC{delta}-p38 kinase-linked cascade mediates the TNF-{alpha}-induced leukocyte adhesion and emigration in the lung airway epithelium. Am J Physiol Lung Cell Mol Physiol 288:L307-L316.
42. Wu WT, Chi KH, Ho FM, Tsao WC, Lin WW. 2004. Proteasome inhibitors upregulate haem oxygenase-1 gene expression: Requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition. Biochem J 379:587-593.
43. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K, Nishikawa S. 2000. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96.
44. Yang BH, Cao DJ, Colman RW, Guo Y-L. 2004. Different roles of ERK and p38 MAP kinases during tube formation from endothelial cells cultured in 3-dimensional collagen matrices. J Cell Physiol 2004:360-369.
45. Zhang J, Shen B, Lin A. 2007. Novel strategies for inhibition of the p38 MAPK pathway. Trend Pharmacol Sci 28:286-295.
46. Zhou Z, Connell MC, MacEwan DJ. 2007. TNFR1-induced NF-[kappa]B, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal 19:1238-1248.